In the current trading session, Rhythm Pharmaceuticals Inc’s (RYTM) stock is trading at the price of $112.15, a gain of 0.31% over last night’s close. So, the stock is trading at a price that is -3.31% less than its 52-week high of $116.00 and 144.32% better than its 52-week low of $45.90. Based on the past 30-day period, the stock price is -3.91% below the high and +16.26% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, RYTM’s SMA-200 is $74.97.
It is also essential to consider RYTM stock ratios like the price-to-sales ratio, which is 47.66 for the last year.
How does Rhythm Pharmaceuticals Inc (RYTM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 15 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.80 in simple terms.
Rhythm Pharmaceuticals Inc (RYTM): Earnings History
If we examine Rhythm Pharmaceuticals Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.75, beating the consensus of -$0.67. In other words, it beat the consensus by -$0.08, resulting in a -12.11% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.75 in contrast with the Outlook of -$0.67. That was a difference of -$0.08 and a surprise of -12.11%.
Rhythm Pharmaceuticals Inc (RYTM): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 13 different analysts, who are expecting earnings to fall in between the range of -0.60 and -0.81 with an average Earnings Estimate of -0.71 which is in contrast with the last year earnings estimate of -0.73 and also replicates 2.74% growth rate year over year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Ownership Details
I will give a breakdown of the key shareholders in Rhythm Pharmaceuticals Inc (RYTM). Recent figures show that the company’s insiders hold 0.65% of shares. A total of 342 institutional investors hold shares in the company, making 105.17% of its stock and 105.86% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund holding total of 2.68 shares that make 4.03% of the company’s total number of shares and are currently priced at 300.7 million.
The securities firm VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds 2.07 shares of RYTM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.12%, and the holding percentage of shares is valued at 232.72 million.
An overview of Rhythm Pharmaceuticals Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Rhythm Pharmaceuticals Inc (RYTM) traded 511,392 shares per day, with a moving average of $107.31 and price change of +12.45. With the moving average of $102.82 and a price change of +9.79, about 584,409 shares changed hands on average over the past 50 days. Finally, RYTM’s 100-day average volume is 663,475 shares, alongside a moving average of $91.98 and a price change of +44.10.
